Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of GBP 1.45 billion. The enterprise value is 1.55 billion.

Market Cap	1.45B
Enterprise Value	1.55B

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.77M
Shares Outstanding	n/a
Shares Change (YoY)	+37.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	28.43M

Valuation Ratios

The trailing PE ratio is 68.86 and the forward PE ratio is 21.05.

PE Ratio	68.86
Forward PE	21.05
PS Ratio	4.46
PB Ratio	4.26
P/TBV Ratio	21.15
P/FCF Ratio	31.97
P/OCF Ratio	18.26
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.74, with an EV/FCF ratio of 34.02.

EV / Earnings	73.29
EV / Sales	4.66
EV / EBITDA	18.74
EV / EBIT	23.92
EV / FCF	34.02

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.

Current Ratio	2.94
Quick Ratio	2.07
Debt / Equity	0.63
Debt / EBITDA	2.66
Debt / FCF	4.75
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 8.03%.

Return on Equity (ROE)	9.95%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	8.03%
Return on Capital Employed (ROCE)	10.82%
Revenue Per Employee	249,151
Profits Per Employee	16,142
Employee Count	1,401
Asset Turnover	0.53
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	23.52
200-Day Moving Average	n/a
Relative Strength Index (RSI)	68.28
Average Volume (20 Days)	137,841

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of GBP 325.89 million and earned 21.11 million in profits. Earnings per share was 0.50.

Revenue	325.89M
Gross Profit	189.66M
Operating Income	63.52M
Pretax Income	34.58M
Net Income	21.11M
EBITDA	78.07M
EBIT	63.52M
Earnings Per Share (EPS)	0.50

Full Income Statement

Balance Sheet

The company has 124.21 million in cash and 216.07 million in debt, giving a net cash position of -91.86 million.

Cash & Cash Equivalents	124.21M
Total Debt	216.07M
Net Cash	-91.86M
Net Cash Per Share	n/a
Equity (Book Value)	341.21M
Book Value Per Share	6.72
Working Capital	171.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 79.60 million and capital expenditures -34.12 million, giving a free cash flow of 45.48 million.

Operating Cash Flow	79.60M
Capital Expenditures	-34.12M
Free Cash Flow	45.48M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.20%, with operating and profit margins of 19.49% and 7.79%.

Gross Margin	58.20%
Operating Margin	19.49%
Pretax Margin	10.61%
Profit Margin	7.79%
EBITDA Margin	23.96%
EBIT Margin	19.49%
FCF Margin	13.96%

Dividends & Yields

Exosens does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.23%
Shareholder Yield	-37.23%
Earnings Yield	1.45%
FCF Yield	3.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 2.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	n/a